The 37 rating InvestorsObserver gives to Immunitybio Inc (IBRX) stock puts it near the bottom of the Biotechnology industry. In addition to scoring higher than 23 percent of stocks in the Biotechnology industry, IBRX’s 37 overall rating means the stock scores better than 37 percent of all stocks.
IBRX has an Overall Score of 37. Find out what this means to you and get the rest of the rankings on IBRX!